Clinical Trial: A Phase II Clinical Study of LBL-024 Combination Therapy in Patients With Advanced Solid Tumour[Substudy 03(ESCC)]

U.S., Jan. 10 -- ClinicalTrials.gov registry received information related to the study (NCT07331155) titled 'A Phase II Clinical Study of LBL-024 Combination Therapy in Patients With Advanced Solid Tumour[Substudy 03(ESCC)]' on Dec. 28, 2025.

Brief Summary: An Open-label, Multicenter, Phase II Clinical Study to Evaluate the Efficacy and Safety of LBL-024 in Combination With Other Drugs for the Treatment of Patients With Advanced Solid Tumour.

Study Start Date: Jan. 30

Study Type: INTERVENTIONAL

Condition: Advanced Solid Tumour

Intervention: DRUG: LBL-024 for Injection

Intravenous infusion

DRUG: Cisplatin Injection

Intravenous infusion

DRUG: Paclitaxel Injection

Intravenous infusion

DRUG: Tislelizumab Injection

Intravenous infu...